As investors adopt a cautious low-volatility strategy, copper prices rise subtly ahead of the Fed's policy decision, reflecting shifts in supply and demand dynamics...
Jo Halliday, CEO of Talking Medicines, has received an MBE for her innovative work in health-tech, transforming patient insights into actionable data for healthcare...
As investors adopt a cautious low-volatility strategy, copper prices rise subtly ahead of the Fed's policy decision, reflecting shifts in supply and demand dynamics...
Jo Halliday, CEO of Talking Medicines, has received an MBE for her innovative work in health-tech, transforming patient insights into actionable data for healthcare...
